JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliw, E. H.
Right arrow Articles by Oates, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliw, E. H.
Right arrow Articles by Oates, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 256, Issue 19, 9924-9931, 10, 1981

Arachidonic acid metabolism in rabbit renal cortex. Formation of two novel dihydroxyeicosatrienoic acids

EH Oliw, JA Lawson, AR Brash and JA Oates

[1-14C]Eicosatetraenoic (arachidonic) acid was incubated with a low speed (17,000 X g) rabbit renal cortical supernatant or with a cortical microsomal suspension fortified with NADPH for 15 min at 37 degrees C. The products which were less polar than prostaglandins on reversed phase high performance liquid chromatography were identified by gas chromatography-mass spectrometry. Both the fortified microsomes and the low speed supernatant formed significant amounts of two novel metabolites, 11,12-dihydroxy-5,8,14-eicosatrienoic acid and 14,15- dihydroxy-5,8,11-eicosatrienoic acid. Other identified products were 19- and 20-hydroxyeicosatetraenoic acid, 19-oxoeicosatetraenoic acid, and in the low speed supernatant, eicosatetraen-1,20-dioic acid. The metabolites were not formed in significant amounts by high speed cortical supernatant or by nonfortified cortical microsomes. Carbon monoxide inhibited formation of these compounds, indicating that they may be formed by the cytochrome P-450-linked renal monooxygenase systems.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. Chen, J.-K. Chen, J. R. Falck, S. Anjaiah, J. H. Capdevila, and R. C. Harris
Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate Metabolite
Mol. Cell. Biol., April 15, 2007; 27(8): 3023 - 3034.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. R. Harder and R. J. Roman
Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus
Circ. Res., April 14, 2006; 98(7): 866 - 867.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. O. Ogungbade, L. A. Akinsanmi, H. Jiang, and A. O. Oyekan
Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F955 - F964.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Cowart, S. Wei, M.-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila
The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands
J. Biol. Chem., September 13, 2002; 277(38): 35105 - 35112.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Zhu, C. Zhang, M. Medhora, and E. R. Jacobs
CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium
J Appl Physiol, July 1, 2002; 93(1): 330 - 337.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Yang, L. Graham, S. Dikalov, R. P. Mason, J. R. Falck, J. K. Liao, and D. C. Zeldin
Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells
Mol. Pharmacol., August 1, 2001; 60(2): 310 - 320.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Honeck, V. Gross, B. Erdmann, E. Kargel, R. Neunaber, A. F. Milia, W. Schneider, F. C. Luft, and W.-H. Schunck
Cytochrome P450-Dependent Renal Arachidonic Acid Metabolism in Desoxycorticosterone Acetate-Salt Hypertensive Mice
Hypertension, October 1, 2000; 36(4): 610 - 616.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. L. Kroetz, L. M. Huse, A. Thuresson, and M. P. Grillo
Developmentally Regulated Expression of the CYP4A Genes in the Spontaneously Hypertensive Rat Kidney
Mol. Pharmacol., September 1, 1997; 52(3): 362 - 372.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. Arima, K. Omata, S. Ito, K. Tsunoda, and K. Abe
20-HETE Requires Increased Vascular Tone to Constrict Rabbit Afferent Arterioles
Hypertension, March 1, 1996; 27(3): 781 - 785.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Wu, C. R. Moomaw, K. B. Tomer, J. R. Falck, and D. C. Zeldin
Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart
J. Biol. Chem., February 16, 1996; 271(7): 3460 - 3468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1981 by the American Society for Biochemistry and Molecular Biology.